Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isotonic saline solution is a sterile, non-pyrogenic solution of 0.9% sodium chloride in water, which is osmotically balanced with human blood. In the context of clinical research at Istanbul University, it is utilized as a sham control (placebo) in a randomized, double-blind trial (NCT04843371) evaluating postoperative pain management. Specifically, it is administered via ultrasound-guided suprascapular and axillary nerve blocks to patients undergoing shoulder arthroscopy. This control arm allows researchers to establish a baseline for pain intensity, measured by the Visual Analog Scale (VAS), and opioid consumption via patient-controlled analgesia (PCA), thereby facilitating a comparison against the efficacy of varying dosages of bupivacaine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic saline solution (Istanbul University).